StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Hydrochloric Acid → 3-Difluoromethoxy-N-(4-methyl-3-piperazin-1-yl-phenyl)-benzenesulfonamide hydrochloride

HRID 1926582
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1926582
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:19]=[C:18]([NH:20][S:21]([C:24]3[CH:29]=[CH:28][CH:27]=[C:26]([O:30][CH:31]([F:33])[F:32])[CH:25]=3)(=[O:23])=[O:22])[CH:17]=[CH:16][C:15]=2[CH3:34])[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:35]>ClCCl.C(OCC)C>[ClH:35].[F:33][CH:31]([F:32])[O:30][C:26]1[CH:25]=[C:24]([S:21]([NH:20][C:18]2[CH:17]=[CH:16][C:15]([CH3:34])=[C:14]([N:11]3[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]3)[CH:19]=2)(=[O:22])=[O:23])[CH:29]=[CH:28][CH:27]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 2

HCID 313Hydrochloric AcidHCID 665998364-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methyl-phenyl]-piperazine-1-carboxylic acid tert-butyl ester

Produkt 1

HCID 469373053-Difluoromethoxy-N-(4-methyl-3-piperazin-1-yl-phenyl)-benzenesulfonamide hydrochloride

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 3283Diethyl EtherLösungsmittel
HCID 6344
Dichloromethane
Lösungsmittel

Versuchsvorschrift

4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methyl-phenyl]-piperazine-1-carboxylic acid tert-butyl ester (0.097 g, 0.195 mmol) was dissolved in 5 mL of dichloromethane. A solution of 0.293 mL of 2N hydrochloric acid in diethyl ether was added and the mixture stirred for 16 h at room temperature. The solvents were evaporated, the residue purified via reversed phase HPLC and fractions containing the product were combined. The pH was adjusted to 9 with aqueous sodium bicarbonate and the aqueous layer extracted with dichloromethane. The organic phase was then dried over magnesium sulphate, filtered and evaporated to dryness. The residue was treated with a solution 2N hydrochloric acid in diethyl ether and the mixture evaporated to dryness to yield the title compound (0.017 mg).

Aufarbeitung

  1. customThe solvents were evaporated
  2. customthe residue purified via reversed phase HPLC and fractions
  3. additioncontaining the product
  4. extractionthe aqueous layer extracted with dichloromethane
  5. dry with materialThe organic phase was then dried over magnesium sulphate
  6. filtrationfiltered
  7. customevaporated to dryness
  8. additionThe residue was treated with a solution 2N hydrochloric acid in diethyl ether
  9. customthe mixture evaporated to dryness

Quellen und Nachweise

ORD-Eintrag
ord-f2e20cd6da63464ea2e9c6762fa0052f
Quelldatensatz
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08183237B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion